Coronavirus

Ending Quarterly Reports Won’t Fix Companies’ Accounting Issues. What Would.

SEC reporting is in need of a larger regulatory overhaul, Martin E. Persson writes in a guest commentary.

By

Martin E. Persson

4 minute read

Go to article

Crypto Stock Market Gambles Are Paying Off. Why That Luck Won’t Last.

Echostar’s spectrum sale, StubHub revives IPO plans, Pfizer says new Covid shots are effective, and more news to start your day.

Long Read

Go to article

Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective 

Ahead of a CDC committee meeting, Pfizer has released early data that it says show that its newest Covid-19 shot works. The committee, hand-picked by JFK Jr., includes many vaccine skeptics.

By

Josh Nathan-Kazis

3 minute read

Go to article

FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use

HHS Secretary Robert F. Kennedy Jr. says the shot will be available for people aged 5 and older.

By

Mackenzie Tatananni

2 minute read

Go to article

Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot.

The Covid-19 pandemic is over, but the virus persists

By

Josh Nathan-Kazis

Long Read

Go to article

Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.

By

Adam Clark

1 minute read

Go to article

Trump Can Reset After Tariffs Ruling, Musk Exit. Why That’s Good for Stocks.

Tariffs are in limbo after court ruling, Powell emphasizes Fed independence, more retail earnings, and more news to start your day.

Long Read

Go to article